FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms25010277 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Po-Yuan Huang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, National Taiwan University Hospital, No. 7, Chung-Shan South Road, Taipei 10012, Taiwan. Hauptthemen laut MEDLINE: Neurofibrosarcoma, Neurofibromatosis 1. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, National Taiwan University Hospital, Executive Yuan, Taiwan and the National Taiwan University Hospital.
Abstract (Originalsprache)
Neurofibromatosis type 1 (NF1) stands as a prevalent neurocutaneous disorder. Approximately a quarter of NF1 patients experience the development of plexiform neurofibromas, potentially progressing into malignant peripheral nerve sheath tumors (MPNST). FT895, an HDAC11 inhibitor, exhibits potent anti-tumor effects on MPNST cells and enhances the cytotoxicity of cordycepin against MPNST. The study aims to investigate the molecular mechanism underlying FT895’s efficacy against MPNST cells. Initially, our study unveiled that FT895 disrupts mitochondrial biogenesis and function. Post-FT895 treatment, reactive oxygen species (ROS) in MPNST notably increased, while mitochondrial DNA copy numbers decreased significantly. Seahorse analysis indicated a considerable decrease in basal, maximal, and ATP-production-coupled respiration following FT895 treatment. Immunostaining highlighted FT895’s role in promoting mitochondrial aggregation without triggering mitophagy, possibly due to reduced levels of XBP1, Parkin, and PINK1 proteins. Moreover, the study using CHIP-qPCR analysis revealed a significant reduction in the copy numbers of promoters of the MPV17L2, POLG, TFAM, PINK1, and Parkin genes. The RNA-seq analysis underscored the prominent role of the HIF-1α signaling pathway post-FT895 treatment, aligning with the observed impairment in mitochondrial respiration. In summary, the study pioneers the revelation that FT895 induces mitochondrial respiratory damage in MPNST cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, National Taiwan University Hospital, No. 7, Chung-Shan South Road, Taipei 10012, Taiwan.
- Department of Medical Genetics, National Taiwan University Hospital, Taipei 10012, Taiwan.
Förderung
- National Science and Technology Council
- National Taiwan University Hospital
- Executive Yuan, Taiwan and the National Taiwan University Hospital
Zitieren
APA
Huang, P. Y., Shih, I. A., Liao, Y. C., You, H. L., & Lee, M. J. (2023). FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25010277
Vancouver
Huang PY, Shih IA, Liao YC, You HL, Lee MJ. FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms25010277
BibTeX
@article{Huang2023,
author = {Huang, Po-Yuan and Shih, I-An and Liao, Ying-Chih and You, Huey-Ling and Lee, Ming-Jen},
title = {FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms25010277}
}
EUVIMED